Fact CheckerSign in

NCT07203066Completed

Effects of Oxaliplatin-Induced Peripheral Neuropathy on Hand Function, Grip Strength and Quality of Life in Colorectal Cancer Patients

Source: ClinicalTrials.gov · Last updated 1 Jun 2026

Brief summary (registry, in English)

The aim of this study is to investigate the effects of oxaliplatin-induced peripheral neuropathy on hand function, grip strength, and quality of life in colorectal cancer patients. Assessing the motor symptoms of CIPN and sharing the results in clinical settings will help guide evidence-based practices and interventions.

Status (registry)
Completed
Study type
Observational
Enrollment
103 (actual)
First submitted
24 Sept 2025
Start date
24 Apr 2025
Primary completion date
20 Jan 2026
Lead sponsor
Fenerbahce University
NCT number
NCT07203066

What you commit to

  • Study type: Observational
  • Participants enrolled: 103
  • From 24 Apr 2025 to the primary completion date, 20 Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Development of peripheral neuropathy due to causes other than chemotherapy (e.g., tumor compression, nutritional disorders, infections, or major systemic diseases such as diabetes mellitus),

Other

  • Presence of mental or cooperation problems.

Who the study is looking for

  • Receiving chemotherapy due to a diagnosis of locally advanced or metastatic colorectal cancer,
  • Having received at least 3 cycles of single or combined oxaliplatin-based chemotherapy,
  • Aged 20 years or older,
  • No speech or hearing impairments,
  • Voluntary participation in the study.

Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cemil Tascioglu City Hospital
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.